29 related articles for article (PubMed ID: 2100734)
1. Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.
Markham A; Brogden RN
Drugs; 1995 Jun; 49(6):1007-22. PubMed ID: 7641600
[TBL] [Abstract][Full Text] [Related]
2. In vitro studies with Bay V 3522, a new oral cephalosporin.
Thomson KS; Sanders CC; Sanders WE
Drugs Exp Clin Res; 1991; 17(3):165-73. PubMed ID: 1914843
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
Hebeisen P; Heinze-Krauss I; Angehrn P; Hohl P; Page MG; Then RL
Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
[TBL] [Abstract][Full Text] [Related]
5. PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
Cornaglia G; Ligozzi M; Bauernfeind A; Satta G; Fontana R
New Microbiol; 1994 Jul; 17(3):203-10. PubMed ID: 7968655
[TBL] [Abstract][Full Text] [Related]
6. Cefdinir: in vitro activity study and effect of human serum.
García-Rodríguez JA; Trujillano-Martín I; García-Sánchez JE
Drugs Exp Clin Res; 1993; 19(2):51-8. PubMed ID: 8223142
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of oral cephalosporin BAY v 3522 compared with other oral cephalosporins.
Locher R; Strässle A; Kayser FH
Drugs Exp Clin Res; 1990; 16(10):515-25. PubMed ID: 2100734
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of ceftriaxone: a review.
Cleeland R; Squires E
Am J Med; 1984 Oct; 77(4C):3-11. PubMed ID: 6093515
[TBL] [Abstract][Full Text] [Related]
9. [Cephalosporins: bacterial resistance measured by penicillin-binding proteins].
Garrido J; López F
Rev Med Chil; 1989 Sep; 117(9):1037-43. PubMed ID: 2519470
[TBL] [Abstract][Full Text] [Related]
10. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
Biek D; Critchley IA; Riccobene TA; Thye DA
J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv9-16. PubMed ID: 21115457
[TBL] [Abstract][Full Text] [Related]
11. Review of the in vitro spectrum of activity of imipenem.
Jones RN
Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of cefodizime.
Knothe H; Shah PM
Infection; 1992; 20 Suppl 1():S3-8. PubMed ID: 1526673
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
